Ministry supports strengthening pharmaceutical cooperation with Japan

These seven sectors were chosen because they can contribute 70% of total gross domestic product (GDP) for manufacturing, 65% of manufacturing exports and 60% of industrial workers.

Jakarta (ANTARA) – The Ministry of Industry supports strengthening cooperation in pharmaceutical and medical device industries between Indonesia and Japan as the two industries are among the seven priority sectors in the Making Indonesia 4.0 roadmap .

The seven priority sectors are food and beverages, automotive, chemicals, textiles and textile products, electronics, pharmaceuticals and medical devices.

“These seven sectors were chosen because they can contribute 70% of total gross domestic product (GDP) for manufacturing, 65% of manufacturing exports and 60% of industrial workers,” the ministry’s acting director-general said. Chemistry, Pharmacy, Pharmacy. and Textile Industries (IKFT), Ignatius Warsito said at a business forum in Osaka, Japan on Saturday, as noted in a written statement on Sunday.

Related News: Ministry provides 10 drug molecules to boost domestic production

According to him, the Ministry of Industry is deepening the industrial structure, increasing investment and implementing the Making Indonesia 4.0 roadmap initiative.

For this reason, the ministry will continuously support activities aimed at establishing comprehensive cooperation, including the implementation of the Indonesia-Japan Business Forum on Pharmaceuticals and Medical Devices, which was held from October 5 to 7, 2022. in Osaka.

“This business forum, which was opened by the Indonesian Ambassador in Tokyo, aims to bring together business players from the pharmaceutical and medical device industry from Indonesia and business players/investors from Japan,” said said the chairman of the Indonesia-Japan bilateral committee of the Indonesian Chamber of Commerce and Industry (Kadin) said Emmanuel L Wanandi.

The business forum was attended by 15 Indonesian business representatives, including nine pharmaceutical and medical device companies, as well as representatives from the Indonesian Association of Pharmaceutical Companies (GPFI) and the Indonesian Association of Medical Device Producers (ASPAKI) .

Related news: Encouraging the independence of the Indonesian pharmaceutical industry

National Food and Drug Administration (BPOM) Director Penny K. Lukito, while delivering her remarks virtually, called on pharmaceutical industry players in Japan to expand their collaborations with Indonesia through technology-based drug research and development.

Meanwhile, the Secretary General of the Ministry of Health, Kunta Wibawa, in Osaka, stressed the importance of the transformation of the health sector, including the transformation of primary services and hospitals, as well as the construction of a resilient health system.

The business forum resulted in the signing of a cooperation agreement between the GPFI and a Japanese partner, the Federation of Pharmaceutical Manufacturers Associations of Japan (FPMAJ), in particular to open up opportunities for collaboration in research and development. as well as co-production.

Related news: National pharmaceutical industry as a global health powerhouse: minister

Related news: The pharmaceutical industry must use research for business development